Home / Explore Insights / A Conversation about Parkinson’s Clinical Trials with Dr. Peter Schmidt and Dr. Mark Stacy
/ News & Media / Recent News / A Conversation About Parkinsons Clinical Trials With Dr Peter Schmidt And Dr Mark Stacy
A Conversation about Parkinson’s Clinical Trials with Dr. Peter Schmidt and Dr. Mark Stacy
Chris Krueger from the Davis Phinney Foundation for Parkinson’s interviews Dr. Peter Schmidt, PhD, and Dr. Mark Stacy, MD on participating in clinical trials for Parkinson’s. Dr. Schmidt, a Davis Phinney Foundation board member, is Rho’s Chief Scientific Officer, supporting clinical trial strategy, design, and operations. Dr. Stacy has been involved in Parkinson’s care and research for over thirty years.
Listen to the podcast here.